EDIT
Editas Medicine, Inc.
NASDAQ · USHealthcareBiotechnology
$2.88-3.36%
Price as of Jul 20, 2026
EDIT capital
Editas Medicine, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 16.33x
- Net debt / equity
- -11.72x
- Debt / assets
- 0.48x
- Debt / EBITDA
- -0.72x
- Net debt / EBITDA
- 0.52x
Liquidity & coverage
- Current ratio
- 3.22x
- Quick ratio
- 3.22x
- Cash ratio
- 3.11x
- Interest coverage
- -100.62x
- EBITDA / interest
- -87.49x
- Working capital
- $88.3M
Cash & dividend
- FCF / debt
- -1.96x
- Cash flow / debt
- -1.95x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.